Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Glycated Hemoglobin A1c (HbA1c) ELISA Kit-Competitive

Product Overview

BioVenic Canine Glycated Hemoglobin A1c (HbA1c) ELISA Kit-Competitive is designed for the quantitative determination of Canine Glycated Hemoglobin A1c (HbA1c) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.

Specifications

Assay Type ELISA-Competitive

Specificity The assay kit is specific for Canine HbA1c.

Target Species Canine

Species Reactivity Canine

Detection Range 15.63-1000 μg/mL

Sensitivity 4.25 μg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 120 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Blood hemoglobin A1c (HbA1c), a specific glycated hemoglobin moiety, is widely employed as a marker for diabetes control in humans. It is also known as glycated hemoglobin, glycosylated hemoglobin, or HbA1c. The concentration of HbA1c provides insight into blood glucose levels over a significantly longer duration than fructosamine concentration. Research indicates that HbA1c levels serve as a valuable tool for assessing the glycemic status of diabetic dogs.

Target/Biomarker Canine HbA1c

Target Synonym Glycosylated Hemoglobin; Hemoglobin A1c; Hb1c; HbAIc; HbAIc

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Norris, O.; Schermerhorn, T. Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs. PloS one. 2022, 17: e0264275.